CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis

Genes Immun. 2002 Feb;3(1):46-9. doi: 10.1038/sj.gene.6363816.

Abstract

The cytotoxic T lymphocyte associated protein 4 (CTLA-4) gene (Ctla-4) is a candidate gene for autoimmune disease. We here report results of two single nucleotide polymorphisms (SNPs) in the Ctla-4, a +49 A/G SNP in CDS1 and a C/T promoter SNP at position -318. There were no differences in these two SNPs between patients and healthy individuals. The frequency of allele G and genotype G/G at position +49 in CDS1 was increased in patients with thymoma when compared with patients with normal and hyperplastic thymic histopathology. Patients with the G/G genotype had signs of immune activation manifested as higher levels of serum IL-1beta and higher percentage of CD28(+) T lymphocytes. There was a strong linkage between the 86bp allele in the 3'-UTR and the A(+49) allele in CDS1. Our results suggest that the SNP at position +49 in CDS1 might be associated with the manifestations of MG.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Abatacept
  • Antigens, CD
  • Antigens, Differentiation / genetics*
  • CD28 Antigens / analysis
  • CTLA-4 Antigen
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Immunoconjugates*
  • Interleukin-1 / blood
  • Interleukin-12 / blood
  • Linkage Disequilibrium
  • Male
  • Myasthenia Gravis / genetics*
  • Myasthenia Gravis / immunology
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic*
  • Sweden
  • T-Lymphocytes / immunology
  • Thymoma / genetics
  • Thymus Hyperplasia / genetics
  • Thymus Neoplasms / genetics

Substances

  • 3' Untranslated Regions
  • Antigens, CD
  • Antigens, Differentiation
  • CD28 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunoconjugates
  • Interleukin-1
  • Interleukin-12
  • Abatacept